The new national guideline from NHS improvement was to notify relevant team of known cancer patient being acutely admitted to hospitals providing acute oncological service. A new uro-oncology alert system by text and e-mail was set up at our District General Hospital accordingly. Aim: To assess the time delay of notification of acute admission. To assess the quality of referrals and outcomes for urological cancers through the system Methods: Prospective assessment of the 53 referrals through the alert system from October 2011 to January 2012. Results: Of the 53, 32 patients had same day notification. Significant delay of more than 72 hours was in 3 patients. 19 of these were for urological cancer related admissions while 6 were for non urological cancers and the rest were for non cancer related events. 5 patients had urgent input in their care that has resulted in better outcomes. Conclusion: About 10% of patients had averted a significant adverse outcome because of the alert. Delay in notification and false notifications are the problems of initial service setup and should be corrected at the patient inclusion level. Longer numbers are needed to ascertain if the alert system would bring about significantly better outcomes.
1153: DO INTRAVENOUS UROGRAMS STILL HAVE A ROLE IN INVESTI-GATING RENAL COLIC? A PROSPECTIVE AUDIT OF PRACTICE IN A DGH
Aims: BAUS and NICE guidelines recommend non-contrast CTKUB for diagnosing renal calculi. This is not always possible in district general hospitals, particularly out-of-hours. We audited imaging of suspected renal colic in a DGH. Methods: Prospective audit of 61 patients with suspected renal colic. Data collected included initial and subsequent imaging and delays to definitive management. Results: CTKUB was first-line imaging in 26 patients (42.6%), intravenous urogram (IVU) in 19 (31.1%), ultrasound scan in 11 (18%), and plain abdominal x-ray in 5 (8.2%). Of those investigated with IVU initially, 84% were performed outside of working hours (0900-1700). 40% of patients who did not have an initial CTKUB subsequently required this for definitive diagnosis. Mean delay between initial and subsequent imaging was >19 hours resulting in an extra night hospital stay for 9 patients, with approximate additional cost to the trust of £4,500. Conclusions: CTKUB has a better specificity and sensitivity than IVU for diagnosing renal calculi. Unless clinically unwell, we recommend CTKUB as first-line in all cases of suspected renal colic, with planned re-attendance for definitive imaging if presenting out-of-hours. This should reduce additional radiation to patients, reduce delays in management and discharge, and provide additional cost-savings to the trust. were independent with some or minimal discomfort. 14 patients required assistance for some of their basic daily needs. 9 patients (2.2%) had sepsis. 131 patients (32.4%) required additional oral analgesia following TRUSB x on days 0, 1 and 2. Mean age of these patients was 63.6 years. This group had mean VAS during the procedure of 4 and when patients reached home was 3.5. Mean maximum VAS on day 1 and 2 was 2.1 and 1.3 respectively. Conclusion: A third of patients require self-medicated analgesia postprocedure. Age alone cannot be used as a criterion to identify patients who will subsequently require analgesia post-procedure, but a higher VAS during the procedure may be indicative. Introduction: Current guidelines on the use of multiparametric MRI in prostate cancer are limited. Its role in diagnosing and staging prostate cancer remains a subject of debate. We designed a questionnaire to assess the current uptake of both staging MRI prior to treatment decision, and the use of multiparametric MRI prior to initial prostate biopsy in target patients. Methods: Questionnaires were handed out to healthcare professionals involved with uro-oncology MDTs. Individuals at each of the urology specialist multi-disciplinary team (SMDT) centres in England were also contacted by email, with a link to the questionnaire. Results: In total, 79 responses from 57 centres were received. Of these, 46 centres reported having a protocol which defines which patients have a staging MRI prior to treatment decision. Nine centres report using multiparametric MRI prior to initial biopsy in target patient, which includes centres using this as part of a research trial or service improvement assessment. Discussion: Our data suggests that the use of multiparametric MRI as an imaging modality is limited. This is in keeping with the current limited data on its value as a diagnostic tool. Further evidence is needed to assess its role within the diagnostic pathway for prostate cancer. Objectives: To compare the accuracy of TRUS biopsy, Transperineal sector biopsy and multiparametric MRI (mp-MRI) at predicting final pathology at radical prostatectomy. Methods: A retrospective diagnostic accuracy study of patients who all had a mp-MRI, a TRUS biopsy and a transperineal sector biopsy followed by a robot assisted radical prostatectomy (RARP) at a single institution between January 2010 and December 2012. The final pathology at radical prostatectomy was compared across MRI, TRUS and TPSP.
Results: 104 consecutive patients were identified with a mean age 62 years (range 40-74) and a median PSA 7.9mg/L (range 0.8-40). The Gleason score at radical prostatectomy was accurate in 71% transperineal sector biopsies but only 27% TRUS biopsies. The Gleason score was upgraded in 77% TRUS biopsies compared to 16% transperineal sector biopsies. There were 23 patients who had extracapsular extension (ECE) at radical prostatectomy but only 25% were predicted by mp-MRI. The MRI did not identify 12 patients staged at T3a and 4 patients staged at T3b. Conclusions: Transperineal sector biopsy was the best predictor of final pathology. Neither TRUS biopsy nor MRI stage predicted final pathology reliably, particularly with regard to extracapsular extension, and this has implications for the use of preoperative nomograms.
